Dental status, dental rehabilitation procedures, demographic and oncological data as potential risk factors for infected osteoradionecrosis of the lower jaw after radiotherapy for oral neoplasms: a retrospective evaluation by unknown
Niewald et al. Radiation Oncology 2013, 8:227
http://www.ro-journal.com/content/8/1/227RESEARCH Open AccessDental status, dental rehabilitation procedures,
demographic and oncological data as potential
risk factors for infected osteoradionecrosis of the
lower jaw after radiotherapy for oral neoplasms: a
retrospective evaluation
Marcus Niewald1*, Jochen Fleckenstein1, Kristina Mang2, Henrik Holtmann3, Wolfgang J Spitzer3
and Christian Rübe1Abstract
Purpose: Retrospective evaluation of the dental status of patients with oral cancer before radiotherapy, the extent
of dental rehabilitation procedures, demographic and radiotherapy data as potential risk factors for development of
infected osteoradionecrosis of the lower jaw.
Methods: A total of 90 patients who had undergone radiotherapy for oral cancer were included into this
retrospective evaluation. None of them had distant metastases. After tumour surgery the patients were referred to
an oral and maxillofacial surgeon for dental examination and the necessary dental rehabilitation procedures
inclusive potential tooth extraction combined with primary soft tissue closure. Adjuvant radiotherapy was started
after complete healing of the gingiva (> 7 days after potential extraction). The majority of patients (n = 74) was
treated with conventionally fractionated radiotherapy with total doses ranging from 50-70Gy whereas further 16
patients received hyperfractionated radiotherapy up to 72Gy. The records of the clinical data were reviewed.
Furthermore, questionnaires were mailed to the patients’ general practitioners and dentists in order to get more
data concerning tumour status and osteoradionecrosis during follow-up.
Results: The patients’ dental status before radiotherapy was generally poor. On average 10 teeth were present, six
of them were regarded to remain conservable. Extensive dental rehabilitation procedures included a mean of 3.7
tooth extractions. Chronic periodontitis with severe attachment loss was found in 40%, dental biofilm in 56%. An
infected osteoradionecrosis (IORN) grade II according to (Schwartz et al., Am J Clin Oncol 25:168-171, 2002) was
diagnosed in 11 of the 90 patients (12%), mostly within the first 4 years after radiotherapy. We could not find
significant prognostic factors for the occurrence of IORN, but a trendwise correlation with impaired dental status,
rehabilitation procedures, fraction size and tumour outcome.
Conclusion: The occurrence of IORN is an important long-term side effect of radiotherapy for oral cancers. From
this data we only can conclude that a poor dental status, conventional fractionation and local tumour progression
may enhance the risk of IORN which is in concordance with the literature.
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Table 1 Patients’ demographical and oncological data
(n = 90)






























Surgery to the lower jaw
Partial resection 16 (23%)






1 × 2.0 72 (80%)
1 × 3.0 2 (2%)
2 × 1.2 15 (17%)
2 × 1.4 1 (1%)
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The dental status of patients with neoplasms of the head
and neck region is known to be more unfavourable com-
pared to healthy persons. Some reasons may be the fre-
quent abuse of nicotine and alcohol and limited dental
hygiene. These factors may increase the risk for developing
infected osteoradionecrosis (IORN) after radiotherapy as a
typical long-term side effect [1]. To our knowledge, IORN
can only be sufficiently avoided performing by extensive
dental rehabilitation procedures including extraction of
teeth. Nevertheless, IORN occurs in a frequency ranging
from 0-22% [2]. Because of the necrosis of the gingiva, ero-
sion and sequestration of the jaw bone and dentoalveolar
abscess formation sufficient chewing and thus nutrition of
the patient can be problematic and thus impair the quality
of life of those patients by a large extent.
16 years ago we have published a retrospective evalu-
ation of the frequency and risk factors for IORN [2].
The frequency of IORN in patients after conventionally
fractionated radiotherapy (total dose 60-70Gy) was 8.6%
while the same rate amounted to 22.9% in patients with
hyperfractionated radiotherapy (total dose 82.8Gy). We
concluded that this excessive occurrence of IORN in pa-
tients having been treated with a hyperfractionated ir-
radiation regimen was probably caused by the high total
dose and a too short interfraction interval.
In the presented analysis, we performed a second
evaluation of frequency and risk factors for IORN in a
totally different collective of patients having undergone
radiotherapy in the years 1993–2001.
Methods
Ninety patients with histologically proven squamous-cell
cancers of the oral cavity treated in the years 1993–2001
were included into this retrospective evaluation. The
majority had primary tumors, one a local recurrence but
had not been irradiated before, none had distant metas-
tases. The mean age at the beginning of radiotherapy
was 57 years, the mean Karnofsky performance index
7.8. Sixty-four patients had undergone prior surgery, the
remaining 24 had not.
Dental examination and treatment procedures were
performed as early as possible with a minimal time interval
of 7–10 days from the last procedure to the beginning of
radiotherapy. All dental extractions were performed
according to a written protocol under “special care” (pri-
mary tissue closure, perioperative antibiotics for 7–10 days
beginning one day before surgery). In the nineties all pa-
tients were advised not to wear their dental prostheses up
to 6–12 months after radiotherapy (today after complete
healing of mucositis) [3,4].
After completion of all dental examination and rehabilita-
tion procedures (Tab. 3), all patients underwent radio-
therapy. 74 patients were treated in a conventionally
Table 2 Dental status before starting radiotherapy






Absent 22.0 0 32 89
Present 10.1 0 32 89
Carious 2.0 0 21 85
Destroyed 1.4 0 21 87
Loose 1.6 0 13 84
Root remainders 0.3 0 5 87
Devital 0.5 0 4 86
Roots – filled
completely
0.2 0 2 84
Roots – filled
incompletely
0.3 0 4 85
Apical
periodontitis
0.3 0 4 86
Cysts 0.2 0 3 85
Retained 0.2 0 2 84
Conservative
treatment possible
5.8 0 30 88
No conservative
treatment possible
4.3 0 25 88
Filled 2.3 0 20 82
Not sufficiently
filled teeth
0.8 0 11 82
Teeth with not
sufficient crowns




Chronic periodontitis with less to moderate attachment loss
Localized 7 (8%)
General 9 (11%) 85














Not sufficient 30 (55%)
n=: data of n patients available.
Table 1 Patients’ demographical and oncological data
(n = 90) (Continued)
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up to 70Gy (n = 23). Ten patients received 64Gy mainly
due to compensation for holidays and accelerator break-
downs while the remaining 10 patients got 36-58Gy mostly
due to deterioration of the general health status during
radiotherapy or the withdrawal of informed consent by the
patient. Sixteen patients were treated in a hyperfractionated
manner with two daily single doses of 1.2Gy with an
interfraction interval of more than 6 hours thus reaching a
total dose of 72Gy (n = 11). The remaining four patients
had total doses ranging from 58.8 to 76.8Gy due to the
same reasons as stated above. Total doses were defined to
the ICRU (International Commission on Radiation Units)
50 reference point. Volume data were available only for the
last few patients so that these are considered here. The dose
distributions were reviewed, the mandible was well within
the 100% isodose.
After production of a fixation mask and the planning
procedure based on a computerized tomography of the
head and neck region, radiotherapy regularly was
performed by laterolateral parallel opposing irregular
portals formed by beam blocks or by a multileaf collima-
tor using 4 – 6 MV photons of a linear accelerator. After
a total dose ranging from 30-50Gy the spinal cord was
spared by a dorsal field reduction. The resulting
underdosage of the level V region was supplemented by
applying lateral opposing electron portals there up to
the primarily intended total dose.
In 17 patients not having been operated on before
chemotherapy consisting of cis-platinum and 5-fluorouracil
was applied simultaneously. Further demographical and
oncological details are depicted in Table 1.
During radiotherapy, the patients received oral care by
the dental colleagues (inhouse). Fluoridation was performed
according to dental advice. Splints were not used normally
due to the experience that the majority of patients used
them incorrectly and thus enhanced oral mucositis.
After radiotherapy, dental follow-up was performed by
their local dentists. Consequently, detailed data about
this phase are not available. Patients with IORN were re-
ferred to the Dept. of Oral and Maxillofacial Surgery for
further treatment.All patients’ records were reviewed. The dental status
and the extent of dental rehabilitation procedures were
extracted from the files in the Department of Oral
Table 3 Dental treatment procedures
Teeth (n=) Mean value Minimum value Maximum value Data available from n patients
Endodontic treatment 0.05 0 2 88
Removal of root remainders with primary tissue closure 0.2 0 5 88
Tooth extraction with primary tissue closure 3.7 0 22 89
Conserving treatment 0.6 0 6 88
Cystectomy 0.1 0 2 87
Healthy teeth remaining after dental rehabilitation 6.2 0 30 89
Edentulous after dental treatment 47 patients (52%)
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pantomograms) were re-examined. Infected osteo-
radionecrosis (IORN) was (at minimum) defined here as
infected mucosal ulcers with eroded mandibular bone
underneath (grade II according to Schwartz et al. [5]). The
radiooncological data were extracted from the files in the
Department of Radiotherapy and Radiooncology. Addition-
ally, standardized questionnaires were mailed to the pa-
tients’ medical doctors, dentists and local authorities three
times within the observation period in order to achieve
additional data concerning tumor outcome, occurrence of
IORN and general health status.
All data were entered into a medical database
(MEDLOG, Parox Comp., Münster, Germany). Distribu-
tions and means were computed. For survival curves
and failure curves (occurrence of IORN) the Kaplan
Meier estimate was used. These curves were compared
using the Mantel Haensel test.
Prognostic parameters for IORN were analyzed uni-
variately by comparison of means and distributions in a
group containing the patients with IORN compared to an-
other group with the patients who never experienced
IORN using the t-test, u-test and chi-square test in the ap-
propriate variables. Multivariate search for independent
prognostic factors was performed by logistic regression.
All patients had given their written informed consent
to surgery, dental rehabilitation procedures and radio-
therapy before treatment. The approval by the local eth-
ics committee was dispensable due to the retrospective
evaluation performed here. This research is in concord-




Conservative treatment 2 (2%)
Tooth extraction with primary tissue closure 14 (16%)




Up to July 2013, 58 patients were dead with a mean
follow-up of 2.4 [0–8.8] years. The patients known to be
alive were seen irregularly, the most recent information
resulted from questionnaires, nearly all patients were
lost to follow-up after on average 7.4 [0–15] years.
Dental findings before radiotherapy
The patients’ dental status was generally poor. On average,
only 10 teeth were present (and thus 22 teeth missing) at
the beginning of therapy in the oral cavity. Of those, on
average 2.0 were carious, 1.5 loose (clinical grade II-III) and
1.4 deeply destroyed. As a result of the meticulous dental
examination only a mean of six teeth was regarded to re-
main conservable on average. 11% of the patients showed
chronic periodontitis with less to moderate attatchment
loss while in 40% chronic periodontitis with severe
attatchment loss was diagnosed.
Additionally, plaque was found frequently; 56% of the pa-
tients had dental biofilm and dental calculi and subgingival
concrements, respectively. The general dental hygiene was
classified separately by a dentist as poor in 55% of the pa-
tients. These findings are based on the data of 53 patients,
further information was not available in the files. The de-
tailed data are depicted in Table 2.
Data on the use of dental prostheses are available for
65/90 patients. Partial prostheses were used by six pa-
tients in the upper jaw and by 22 patients in the lower
jaw. Complete prostheses were used by 34 patients in
the upper jaw and by 15 patients in the lower jaw. The
patients had been counselled not to wear their pros-
theses during radiotherapy and 12 months afterwards.
Dental rehabilitation procedures before and after
radiotherapy
All patients were referred to the dentist and oro-
maxillofacial surgeon for dental and surgical treatment,
89/90 have been seen there. The dental rehabilitation pro-
cedures necessary before radiotherapy were very extensive:
on average 3.7 teeth had to be extracted followed by pri-
mary soft tissue closure of the extraction alveoles. The


























Figure 1 Occurrence of IORN over time (Kaplan-Meier estimate and 95% confidence interval).
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10 days using soft diet, valid antibiosis and prosthodontic
abstention. The detailed data to this point are summarized
in Table 3.
During follow-up after radiotherapy additional dental
treatment procedures were necessary in 17 patients –
the data are depicted in Table 4.Frequency, risk factors and therapy of infected
osteoradionecrosis
11 patients (12%) were found to have developed infected
osteoradionecrosis during follow-up. The one-year preva-
lence was 5%, the two- and three-year prevalence 15%.
All of them had been treated by conventionally frac-
tionated radiotherapy applying doses of 50Gy (1 pat.),
60Gy (4 pats.), 64Gy (3 pats.), and 70Gy (3 pats.), re-
spectively. Nine of these patients had undergone tumour
resection, two had not. Additionally, two patients had
undergone a partial resection of the lower jaw, further
three patients a continuity resection of the lower jaw. In
total, 9/64 patients (14%) having been operated on had
IORN compared to only 8% in the non-surgical patients.
In the group treated by hyperfractionation no patient
with IORN could be identified. The Kaplan Meier esti-
mate shows that IORN normally occurs within the first
four years after radiotherapy, after that time new IORN
cases were very rare (Figure 1).
All parameters mentioned in Tables 1, 2, 3 and 4 were
tested univariately for potential prognostic significance
for the occurrence of IORN. Results of this analysis are
depicted in Table 5. The number of carious teeth and
of odontogenic cysts in the lower jaw were foundsignificant prognostic factors, for the numbers of present
teeth before dental treatment and of remaining teeth
after dental treatment a trend can be assumed. Multi-
variate analysis showed “odontogenic cysts” as the only
significant factor.
The treatment of infected osteoradionecrosis consisted
of non-continuously bone resection in two patients, sur-
gery without bone resection in further three. Two pa-
tients were treated conservatively while one underwent
hyperbaric oxygen therapy. The remaining three patients
were not treated at all.Oncological results
Due to the patients’ very limited compliance the out-
come data were incomplete. The following numbers
show the frequency of recurrence or progression com-
pared to the number of patients with sufficient data
available.
A local tumor progression was found in 25/73 patients
(34%), a progression in the regional lymph nodes in
12/61 patients (20%), and distant metastases in 12/59
patients (20%). No sufficient data to this point were
available from the remaining patients. The median sur-
vival time was 3.1 years. The two-year survival rate was
62% while the five-year survival rate amounted to 41%.
The Kaplan-Meier estimate for overall survival is
depicted in Figure 2. As to acute side effects occurring
during or shortly after radiotherapy, oral mucositis grade
II WHO was found in 47 patients (54%), grades III and
IV in further 5 patients (6%, n = 87). Sialadenosis (dry-
ness of mouth) as a typical long-term side effect of
radiotherapy was found in 72 patients (82%; grade 1












Roots – filled completely 0.555




Conservative treatment possible 0.129
No conservative treatment possible 0.830
Filled 0.758
Not sufficiently filled teeth 0.517
Teeth with not sufficient crowns 0.897
Item
















Partial prosthesis in lower jaw 0.5254
Complete prosthesis in lower jaw 0.9026
Dental treatment before radiotherapy
Endodontic treatment 0.474




Table 5 Prognostic factors for the occurrence of IORN in
the lower jaw (Continued)
Healthy teeth remaining after dental rehabilitation 0.085 Trend
Dental treatment after radiotherapy 0.768
Demographic and oncological data
Age 0.118









Odontogenic cysts 0.0180 Significant
Healthy teeth remaining after dental treatment 0.1552
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(43%), grade 3: 12 patients (14%); n = 88).
Discussion
The authors are well aware of the limitations of this
retrospective evaluation. In this nearly homogenous col-
lective of patients with oral cavity cancer having under-
gone radiotherapy +/− surgery, we have found complete
data sets concerning dental status and restoration proce-
dures of nearly all patients. The IORN data have been
investigated meticulously, but due to the known
incompliance of head and neck patients we cannot ex-
clude that single events did not become known to the
authors.
Dental health status
The comparison of our data concerning dental findings be-
fore radiotherapy to those of the Forth German Trial of
Oral Health (original name in German: IV. Deutsche
Mundgesundheitsstudie des Instituts der Deutschen
Zahnärzte DMS IV) resulted in notable differences [6].
Summarizing the data of more than 4000 Germans before
dental treatment, in adults (33–44 years of age) on average
14.5 teeth were found carious, in older people (> = 45 years
of age) 22.1 teeth. These teeth were rehabilitated completely
in 95.6% and in 94.8%, respectively. A mean of 2.77 teeth in
adults and of 14.2 teeth in older people were missing. 72%
of the adults and 60.6% of the seniors were found to per-
form sufficient mouth hygiene. All these values were im-
proved compared to the results of a former trial in 1997.
On the other hand, the frequency of periodontitis was ris-
ing (moderate in 52.9% and intense in 39.8% of the popula-
tion). Compared to those data our findings in patients with




























Figure 2 Overall survival (Kaplan-Meier estimate and 95% confidence interval).
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equally detailed analyses are rare. Jham et al. reported 2008
a collective of 207 patients with head and neck cancer with
similar dental findings detecting periodontal disease in 41%,
retained roots in 21%, carious teeth in 12%, and unerupted
teeth in 5.8% of their patients, resulting in an IORN rate of
5.5% [7]. Schuurhuis et al. summarized 2011 the data of
185 patients and found oral infectious foci in 75%, a peri-
odontal pocket depth of more than 6 mm in 23%, severe
caries in 4%, impacted teeth in 4%, and residual root tips in
3%. Tooth extractions had to be performed in 30% of theTable 6 Dental status and rehabilitation procedures in the lit





(n = 82) [9]
2011 No information No
Guggenheimer et al.
(n = 947) [10]
1994 Edentulous: 59% No
Partially edentulous: 9%




(n = 100) [11]
1993 Tumour vs. control patients:
Tartar > 3 mm: 40.91 vs. 21.98%
No
Decayed teeth >50% : 27.2 vs. 3.9%
Lockhart et al.
(n = 131) [12]
1994 Alveolar bone loss: 66% Nee
97%




(n = 207) [7]
2008 Periodontal disease: 41% No
Residual root: 21.2%
Caries 12%
Unerupted tooth: 5.8%patients, a mean of 7.7 teeth had to be removed. Periodon-
tal treatment was performed in 6%. IORN was diagnosed in
11% [8]. Further literature data on this topic have been
summarized in Table 6 [7,9-12]. In general, tumor patients
frequently show a noncompliance in routine dental care
and daily oral hygiene. Tumor diagnosis did not change the
patients’ habits: Lockhart and al. [12] stated that 97% of
their patients needed dental care before radiotherapy, but
only 81% underwent the indicated treatment.
We can summarize from this data that patients with




information Average (median) date of last dental visit:
66.76 months (18 months) before radiotherapy
information
information Tumour vs. control patients
Never tooth brushing 44.9 vs. 23.5%
Dental visit more than once a year: 6% vs. 43.5%
ding dental care: Noncompliant with routine dental care: 76%
not seek the
icated treatment:
Noncompliant with routine oral hygiene: 65%
information
Table 7 Incidence of IORN of the upper and lower jaw in the literature
Author group Year of publication Incidence Remarks
Ben-David et al. [13] (n = 176) 2007 0 Multiple tumour localizations
Primary treatment (no surgery)
IMRT
108/176 radiochemotherapy
Berger et al. [14] 2010 1-5% Literature survey
Crombie et al. [15] (n = 54) 2012 36% 53/54 radiochemotherapy
Gomez et al. [16] (n = 168) 2011 1.2% Multiple tumour localizations
IMRT
Gomez et al. [29] (n = 35) 2009 5% IMRT
Jerecek-Fosså et al. [17] 2002 0.4-56% Literature survey
Jham et al. [7] (n = 207) 2008 5.5% Head and neck cancer
Katsura et al. [18] (n = 39) 2008 15%
Lee et al. [19] (n = 189) 2008 6.6% Oral cavity and oropharynx
Monnier et al. [20] (n = 73) 2011 40% Oral cavity and oropharynx
Oh et al. [21] (n = 81) 2004 4.9%
Reuther et al. [5] (n = 830) 2003 8.2% Oral cavity and oropharynx
Stenson et al. [22] (n = 27) 2010 18.4% Surgery, adjuvant radiochemotherapy
Storey et al. [23] (n = 83) 2001 6% Malignant submandibular tumours
Studer et al. [24] (n = 304) 2011 Grade 2 EORTC: 1.6% Oral cavity and oropharynx
Conventional dental care vs. risk-adapted dental care
IMRT
Thiel [25] 1989 4-35% Literature survey
Thorn et al. [26] (n = 80) 2000 74%/3 years Multiple tumour localizations
Tsai et al. [27] (n = 402) 2013 7.5% Oropharyngeal cancer, median time to IORN 8 months
Turner et al. [28] (n = 333) 1996 5.9%
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findings are well within the range of the data taken from
the literature seen above.
Frequency of IORN
The incidence of IORN varies widely (0 – 74%) as
depicted in Table 7 whereas the majority of data are in a
range of 5-10%. However, the comparison of these values
to each other and to our results is very difficult due to a
different definition or staging of IORN, different tumor
localizations, therapy schedules, radiation techniques
and dosages. Our results fit well within the range of data
taken from the literature [5,7,13-29]. One of the data
sets in the literature most comparable to our dataset has
been published by Lee et al. [19] who experienced com-
parable IORN frequencies in a collective of patients hav-
ing been operated on mainly.
Risk factors for the development of IORN
Numerous prognostic factors for the development of IORN
have been tested and published. A selection of these issummarized in Table 8 [3,4,14,17,18,20,27,28,30-39]. The
localization of the primary tumour in the oral cavity with
its microbial colonization and the abundant involvement of
the mandibular bone with its unique blood supply probably
promotes IORN. Unfavourable dental status, periodontal
disease and irritation of the gingiva by pressure sore trig-
gered by dental prosthesis are important as well as dental
extractions before and especially after radiotherapy and do
also promote an infestation of the upper jaw.
Radiation dose should not exceed 60 – 66Gy to the
mandibular bone whenever possible, the target volume
within the bone should be limited. Some authors
regard hyperfractionation a risk factor for IORN whereas
Intensity modulated radiotherapy (IMRT) has been found
advantageous compared to conventional 3D-planned radio-
therapy. Additional factors may be chemotherapy, higher
body mass index and the use of steroids.
We found odontogenic cysts and carious teeth to
be significant prognostic factors univariately and
odontogenic cysts multivariately. This rather unusual
finding may result from the low number of patients in
Table 8 Risk factors for IORN of the upper and lower jaw in the literature
Author group Year of publication Risk factor(s) Remarks
Ahmed et al. [30] 2009 Intensity modulated radiotherapy (IMRT) advantageous compared
to conventional radiotherapy
Berger et al. [14] 2010 Total dose >66Gy Literature survey
Bhide et al. [31] 2012 Total dose > 60Gy Literature survey
Volume of mandible within the treatment field. Trauma related
ORN after lower doses
IMRT






Lack of pre-RT dental extractions
Goldwasser et al. [33] 2007 Higher body mass index Multivariate analysis
Use of steroids
Radiation dose >66Gy
Jerecek-Fosså et al. [17] 2002 Total dose Literature survey, only part of
the factions mentioned in the
paper cited hereBrachytherapy dose
Dose per fraction
Interval between fractions




Dental extractions after radiotherapy
Katsura et al. [18] 2008 Oral health status after radiotherapy
Periodontal pocket depth
Dental plaque
Alveolar bone loss level
Radiographic periodontal status
Lee et al. [19] 2009 Univariate: Mandibular surgery Multivariate analysis:
Mandibular surgery
Co-60 BED >106.2Gy
Lozza et al. [35] 1997 Dose rate Brachytherapy exclusively
Reference volume





Mode of radiation delivery
Dental status
Time from radiation therapy until the onset of ORN
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Table 8 Risk factors for IORN of the upper and lower jaw in the literature (Continued)
Monnier et al. [20] 2011 Oral cavity tumours Multivariate analysis: bone
surgery
Bone invasion
Surgery prior to radiotherapy
Bone surgery
Nabil et al. [36] 2012 Hyperfractionation Literature survey
Reduced risk after accelerated radiotherapy with reduced dose
Reuther et al. [4] 2003 Advanced tumours
Segmental resection of the mandible
Tooth extractions (pre/post RT)
Pre-surgical radiotherapy worse than post-surgical radiotherapy
Støre and Boysen [37] 2000 Tumour localization in tongue and floor of mouth
trauma





Dental extractions before and after radiotherapy
Bone surgery because of remaining or recurrent tumours









Turner et al. [24] 1996 Bone involvement
Synchronous Methotrexate
Scattered dose from elective
neck treatment
Increasing dose
Increasing target volumes for doses <55Gy
Dental extractions
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data were incomplete.
Apart from this analysis, hyperfractionation seemed to
have a protective effect whereas this could not be examined
further due to the small number of events. In our ancient
publication on this topic [2] (a very detailed comparison is
currently under preparation) we experienced a very high
frequency of IORN after hyperfractionated radiotherapy
which may have been caused by to high total doses on the
one hand and a too short interfraction interval (time inter-
val between the two daily fractions) on the other hand.Both factors have been taken into account here, conse-
quently the results were improved markedly.
An important paper has been published by Tsai et al.
in 2013 [27]. They reviewed the records of patients with
small oropharyngeal cancers having undergone radio-
therapy or radiochemotherapy. The overall prevalence of
IORN was 7.5%, higher doses, use of nicotine and alco-
hol, dental status as well as more advanced tumors were
found significant risk factors for the development of
IORT. In contrast to this paper our patients’ primary
situation seems more unfavorable: we only examined
Niewald et al. Radiation Oncology 2013, 8:227 Page 11 of 12
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within the 100%-isodose, thus we applied even higher
doses to a large amount of bone. Furthermore, older
techniques have been used; unfortunately, no informa-
tion about fractionation has been given. Consequently, a
higher prevalence of IORN here seems to be explainable.
Conclusions
In our patient collective the dental status was very poor,
extensive dental and oral and maxillofacial restoration
procedures had to be performed. This meticulous dental
care resulted in an incidence of IORN of 12%, all of
them had undergone conventionally fractionated radio-
therapy. It was very interesting to see that in the
hyperfractionated group no IORN occurred at all. Sig-
nificant prognostic factors could not be found. Our data
fit well to those taken from the literature.
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